SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Greater China Junior Stocks -- Ignore unavailable to you. Want to Upgrade?


To: manny t who wrote (1050)12/23/2005 2:49:49 PM
From: hui zhou  Respond to of 1992
 
This stock was recommended by Barron last year as a stock of the year of 05 pick by an analyst who's firm is invested in. I don't know what happen to this company. Looks like business plan is completely falling apart.

Volume so far is not so high. Small traders may not discover it until Monday(if market is open).

If I don't visit this board, I don't know. I can't see it on Yahoo board movers' list since the share price <1.



To: manny t who wrote (1050)12/26/2005 12:06:22 AM
From: manny t  Respond to of 1992
 
AXJ,

A little speculation from the same MSGI on IHub:

"Wade, the revenues/profits are mind boggling. Lets say that they only get 5% of the 90 mil people in Asia that have diabetes to take their drug (4.5 mil people). Lets also say the pills only cost 10 cents per tablet and you only take one per day. Thats 90 tablets per quarter at 10 cents apiece is $9 per person per quarter. That is about $40 mil per quarter in revenue. If margins are about 40% that is $16 mil per quarter profit. With 20 mil shares OS, that is 80 cents per quarter profit or $3.20 per year profit. At a PE of 20, that is $64 per share. Now I have heard figures of 25 cents per tablet. And what if they get 10% of the 90 mil to take the drug? What if they sell the drug in Europe and North America? What if you have to take 3 tablets per day instead of one? The figures then become mind boggling."